Paper # 850 
Antiretroviral Drug Resistance Mutations in HIV-1-infected Ugandan Children Perinatally Exposed to Single-dose Nevirapine following Virologic Failure to an NNRTI-based Regimen
Victor Musiime*, F Ssali, I Nankya, J Kayiwa, H Kizito, W Namala, E Natukunda, F Kyeyune, C Kityo, and P Mugyenyi
Joint Clin Res Ctr, Kampala, Uganda
Background: HIV-1 infected children with perinatal
exposure to single dose nevirapine (SDN) have been observed to have virologic
failure when initiated on non-nucleoside reverse transcriptase inhibitor
(NNRTI) based HAART, probably because the exposure predisposes them to
developing NNRTI resistance mutations. We investigated the Drug Resistance
Mutations (DRM) in HIV-1 infected SDN exposed children with virologic failure
following initiation on NNRTI based HAART.
Methods: In this study, 116 HIV infected children
below 5 years of age at HAART initiation were recruited into a cohort at Joint
Clinical Research Center (JCRC) in Uganda. Forty-one children (63.4% girls,
median age at HAART initiation 6 months) had prior exposure to SDN. We studied
the NNRTI and nucleoside reverse transcriptase inhibitor (NRTI) genotypic
resistance profiles of 20 children (15 exposed and 5 unexposed to SDN) that had
virologic failure at week 24 and/or at week48 following initiation of NNRTI-based
HAART. The resistance sequencing was done using in house primers and edited
using BioEdit Sequence Alignment Editor and analyzed using the HIV drug
resistance database of Stanford University.
Results: Virologic failure was in 17/26 (65.4%) SDN
exposed compared to 19/52 (36.5%) unexposed (P =0.0127); and 18/29
(62.1%) SDN exposed compared to 17/53 (32.1%) unexposed children (P =0.0086)
at weeks 24 and 48, respectively. In the exposed the commonest NNRTI DRM
were: Y181C (4), G190AG (4), K103N (3), V108IV (3), K103R (2); others were:
Y181V, M230L, V106A, P225ST, F227FL, A98G and K101E. The commonest NRTI DRM in
the SDN exposed were: M184V (10), D67N (4), K70R (4), T219E (2), K219Q (2),
E44D (2), T215F (2), T215IT (2); others were: K65R, K219R, T215FY, T215Y, A62V,
T69N, V75I, M41L and V118I. Less diversity was observed in the 5 unexposed
children with the commonest NNRTI DRM being K103N (4); the others were: K103RS,
K238N, G190AG and M230L, and the commonest NRTI DRM was M184V (5), others
being: K70R, D67N and L74V. 12 and 8 children had HIV-1 subtypes D and A,
respectively.
Conclusion: HIV infected children with virologic
failure on NNRTI based HAART and prior perinatal exposure to SDN have multiple
NNRTI drug resistance mutations commonly Y181C, G190AG, K103N, V108IV as well
as multiple NRTI drug resistance mutations commonly M184V, D67N and K70R. Fewer
mutations were observed in the children with no prior SDN exposure, making the
exposed with virologic failure more likely to have multiple drug resistance.
|